Novacyt (NCYT) Competitors GBX 39 -1.60 (-3.94%) As of 12:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock NCYT vs. EKF, CREO, IUG, POLX, IHC, AVO, MHC, RUA, SUN, and BELLShould you be buying Novacyt stock or one of its competitors? The main competitors of Novacyt include EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), and Belluscura (BELL). These companies are all part of the "medical devices" industry. Novacyt vs. EKF Diagnostics Creo Medical Group Intelligent Ultrasound Group Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy MyHealthChecked RUA Life Sciences Surgical Innovations Group Belluscura EKF Diagnostics (LON:EKF) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation. Which has more volatility & risk, EKF or NCYT? EKF Diagnostics has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.86, meaning that its share price is 286% less volatile than the S&P 500. Does the MarketBeat Community prefer EKF or NCYT? EKF Diagnostics received 291 more outperform votes than Novacyt when rated by MarketBeat users. Likewise, 76.76% of users gave EKF Diagnostics an outperform vote while only 58.06% of users gave Novacyt an outperform vote. CompanyUnderperformOutperformEKF DiagnosticsOutperform Votes32776.76% Underperform Votes9923.24% NovacytOutperform Votes3658.06% Underperform Votes2641.94% Which has preferable earnings & valuation, EKF or NCYT? EKF Diagnostics has higher revenue and earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEKF Diagnostics£49.91M1.88£4.68M£1.0719.64Novacyt£18.12M1.49-£36.80M-£54.44-0.72 Does the media prefer EKF or NCYT? In the previous week, Novacyt had 1 more articles in the media than EKF Diagnostics. MarketBeat recorded 1 mentions for Novacyt and 0 mentions for EKF Diagnostics. Novacyt's average media sentiment score of 1.53 beat EKF Diagnostics' score of 0.67 indicating that Novacyt is being referred to more favorably in the news media. Company Overall Sentiment EKF Diagnostics Positive Novacyt Very Positive Do institutionals & insiders have more ownership in EKF or NCYT? 70.3% of EKF Diagnostics shares are held by institutional investors. Comparatively, 0.1% of Novacyt shares are held by institutional investors. 5.2% of EKF Diagnostics shares are held by insiders. Comparatively, 3.1% of Novacyt shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is EKF or NCYT more profitable? EKF Diagnostics has a net margin of 9.37% compared to Novacyt's net margin of -203.06%. EKF Diagnostics' return on equity of 7.03% beat Novacyt's return on equity.Company Net Margins Return on Equity Return on Assets EKF Diagnostics9.37% 7.03% 5.27% Novacyt -203.06%-47.73%-27.98% SummaryEKF Diagnostics beats Novacyt on 13 of the 15 factors compared between the two stocks. Remove Ads Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NCYT vs. The Competition Export to ExcelMetricNovacytMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£26.95M£3.34B£5.24B£2.41BDividend YieldN/A2.44%4.87%4.95%P/E Ratio-0.7275.5621.20127.76Price / Sales1.49122.32356.35257,920.01Price / Cash0.5815.9938.1627.87Price / Book0.393.636.234.33Net Income-£36.80M£126.02M£3.20B£5.76B7 Day Performance-6.15%-4.85%-8.32%2.04%1 Month Performance-19.25%-5.82%-3.36%0.73%1 Year Performance-9.30%-13.15%2.72%92.67% Novacyt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NCYTNovacytN/AGBX 39-3.9%N/A-9.6%£26.95M£18.12M-0.72120Positive NewsGap DownEKFEKF DiagnosticsN/AGBX 22.11-4.9%N/A-18.3%£98.28M£49.91M20.58356CREOCreo Medical GroupN/AGBX 13-1.0%N/A-67.4%£52.56M£33.87M-2.06279News CoverageIUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165POLXPolarean ImagingN/AGBX 1.12-0.9%N/A-76.4%£16.37M£5.21M-0.2928IHCInspiration Healthcare GroupN/AGBX 16.60-0.9%N/A-42.8%£14.38M£42.87M-1.14224Positive NewsGap DownAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownMHCMyHealthCheckedN/AGBX 15.40+1.0%N/A+24.4%£8.01M£9.43M-7.6816RUARUA Life SciencesN/AGBX 11.88-1.0%N/A+27.1%£7.37M£4.05M-2.7748SUNSurgical Innovations GroupN/AGBX 0.57+2.7%N/A+14.0%£5.27M£12.54M-21.1180Gap UpBELLBelluscuraN/AGBX 1.50-4.8%N/A-86.3%£3.78M£2.87M-0.1624Gap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies EKF Diagnostics Alternatives Creo Medical Group Alternatives Intelligent Ultrasound Group Alternatives Polarean Imaging Alternatives Inspiration Healthcare Group Alternatives Advanced Oncotherapy Alternatives MyHealthChecked Alternatives RUA Life Sciences Alternatives Surgical Innovations Group Alternatives Belluscura Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:NCYT) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novacyt S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novacyt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.